Stay updated on Fostamatinib in Warm Autoimmune Hemolytic Anemia Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib in Warm Autoimmune Hemolytic Anemia Clinical Trial page.

Latest updates to the Fostamatinib in Warm Autoimmune Hemolytic Anemia Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study objectives and criteria related to the treatment of warm antibody autoimmune hemolytic anemia, while a new version number has been added.SummaryDifference6%
- Check39 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check75 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check97 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check104 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Fostamatinib in Warm Autoimmune Hemolytic Anemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib in Warm Autoimmune Hemolytic Anemia Clinical Trial page.